Molecular pathology has become increasingly important in cancer diagnosis and treatment. Techniques such as polymerase chain reaction (PCR) and next-generation sequencing (NGS) can identify genetic mutations and alterations that drive cancer growth. This allows for the development of personalized treatment plans based on the molecular profile of the tumor.
